Managing Director at Gordon Dyal & Co. Advisory Group LP- 15 years of experience in Corporate Finance / M&A with a deep expertise in valuation, process and tactics - Completed over $100B+ of complex transactions across M&A, capital structure, and strategic advisory- Wide-ranging global perspective: lived, worked or completed transactions throughout the Americas, Europe, and AsiaSpecialties and Current Focus: Large Cap Coverage | Public Market M&A | Stock-for-Stock Transactions | Cross-Border M&A US/Europe | Corporate Defense | Strategic TransformationsRepresentative transactions include:- AngloGoldAshanti cash/stock acquisition of Centamin plc ($2.5bn)- Novozymes all-stock acquisition of Chr. Hansen ($12.4bn)- Avantor acquisition of Masterflex ($2.9bn)- Northrop Grumman acquisition of OrbitalATK ($9.2bn)- Linde all-stock merger of equals with Praxair ($90bn)